STOCK TITAN

Maravai LifeSciences Announces November 2023 Investor Conference Schedule

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Maravai LifeSciences, Inc. (NASDAQ: MRVI) to participate in investor conferences in November 2023. CEO and CFO to join fireside chats at Stifel Healthcare Conference and Jefferies London Healthcare Conference. Webcasts available on Maravai's Investor Relations website.
Positive
  • None.
Negative
  • None.

SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the month of November.

On November 14, 2023, at 10:55 a.m. EST, Trey Martin, Chief Executive Officer (CEO) and Kevin Herde, Chief Financial Officer (CFO), will participate in a fireside chat at the Stifel Healthcare Conference, 2023, being held at the Lotte New York Palace Hotel, in New York City, NY.

On November 16, 2023, at 2:00 p.m. GMT, Trey Martin, Chief Executive Officer (CEO) and Kevin Herde, Chief Financial Officer (CFO), will participate in a fireside chat at the Jefferies London Healthcare Conference, 2023, being held at the Waldorf Hilton, in London, England.

A live webcast of the presentations will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under News & Events. An archived version of the webcasts will also be available on the Maravai website following the completion of each event.

About Maravai

Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapies companies.

For more information about Maravai LifeSciences, visit www.maravai.com.

Contact Information:

Media Contact:
Sara Michelmore
MacDougall Advisors
+1 781-235-3060
maravai@macdougall.bio

Investor Contact:
Deb Hart
Maravai LifeSciences
+1 858-988-5917
ir@maravai.com


Maravai LifeSciences, Inc. (MRVI) is participating in investor conferences in November 2023, with the CEO and CFO joining fireside chats at the Stifel Healthcare Conference and Jefferies London Healthcare Conference.

The Stifel Healthcare Conference is scheduled for November 14, 2023, at the Lotte New York Palace Hotel, New York City, NY. The Jefferies London Healthcare Conference will take place on November 16, 2023, at the Waldorf Hilton, London, England.

A live webcast of the presentations will be available on the Maravai LifeSciences Investor Relations website, under News & Events. Additionally, archived versions of the webcasts will be accessible on the Maravai website after each event.
Maravai LifeSciences Holdings Inc

NASDAQ:MRVI

MRVI Rankings

MRVI Latest News

MRVI Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Commercial Services, Miscellaneous Commercial Services
US
San Diego

About MRVI

maravai lifesciences catalyzes the growth of successful, entrepreneurial life science companies by providing expertise, capital, processes and systems so that they can continue to serve scientists who are striving to improve human health. current maravai lifesciences portfolio companies provide enabling tools and services in the life sciences research and bioproduction industries that accelerate breakthrough discoveries in areas such as genomics, proteomics, and biotherapeutic development. maravai lifesciences was formed in march 2014 through a partnership with gtcr, a leading private equity firm. our mission is to build a transformative life sciences reagents company by acquiring outstanding businesses and accelerating their growth. since our founding, we have acquired four companies, each a leader in its market segment. vector laboratories has led the market for labeling and detection products used by researchers in immunohistochemistry, immunofluorescence and related techniques. tri